Chenguang Biotech Group (SHE:300138) — Stock Price

CN¥11.70 CNY
▲ 4.19% today

Chenguang Biotech Group (SHE:300138) is currently trading at CN¥11.70 CNY, up 4.19% today. Over the past 52 weeks, shares have ranged between CN¥8.94 and CN¥15.71. This page tracks Chenguang Biotech Group's live share price on the SHE exchange, its daily price and volume history, and — where reported — its income statement, balance sheet, cash flow statement, and earnings history. For company valuation and market capitalisation context, see Chenguang Biotech Group market capitalisation.

Chenguang Biotech Group (300138) Stock Price Chart — Daily History & Trading Volume

The chart below tracks Chenguang Biotech Group's daily closing share price and trading volume on the SHE exchange over the past year, giving a clear view of recent price momentum and liquidity.

Chenguang Biotech Group Income Statement — Revenue, Profit & Earnings by Year

Chenguang Biotech Group's annual income statement shows how revenue converts into profit each fiscal year, including gross profit, operating income, EBITDA, and net income.

Fiscal Year 20242023202220212020
Total Revenue CN¥6.99 Billion CN¥6.87 Billion CN¥6.30 Billion CN¥4.87 Billion CN¥3.91 Billion
Cost of Revenue CN¥6.44 Billion CN¥6.07 Billion CN¥5.42 Billion CN¥4.15 Billion CN¥3.26 Billion
Gross Profit CN¥556.90 Million CN¥797.92 Million CN¥877.73 Million CN¥719.08 Million CN¥652.01 Million
Research & Development CN¥128.60 Million CN¥97.40 Million CN¥129.03 Million CN¥94.79 Million CN¥82.58 Million
SG&A CN¥46.36 Million CN¥48.49 Million CN¥41.77 Million CN¥35.34 Million CN¥39.95 Million
Total Operating Expenses CN¥450.86 Million CN¥249.59 Million CN¥370.51 Million CN¥290.44 Million CN¥254.30 Million
Operating Income CN¥106.04 Million CN¥548.32 Million CN¥487.01 Million CN¥384.87 Million CN¥311.05 Million
EBITDA CN¥383.86 Million CN¥781.13 Million CN¥689.32 Million CN¥581.72 Million CN¥502.98 Million
EBIT CN¥216.71 Million CN¥628.10 Million CN¥544.00 Million CN¥451.21 Million CN¥390.69 Million
Interest Expense CN¥118.38 Million CN¥83.51 Million CN¥68.91 Million CN¥54.37 Million CN¥79.31 Million
Income Before Tax CN¥106.95 Million CN¥555.82 Million CN¥501.76 Million CN¥398.07 Million CN¥312.62 Million
Income Tax Expense CN¥28.99 Million CN¥61.65 Million CN¥65.67 Million CN¥47.47 Million CN¥46.49 Million
Net Income CN¥94.05 Million CN¥479.72 Million CN¥434.03 Million CN¥351.51 Million CN¥267.74 Million

Chenguang Biotech Group Balance Sheet — Assets, Liabilities & Shareholder Equity

The balance sheet below summarizes Chenguang Biotech Group's financial position at each fiscal year-end — what it owns (assets), what it owes (liabilities), and the resulting shareholder equity.

Fiscal Year 20242023202220212020
Total Assets CN¥9.02 Billion CN¥8.54 Billion CN¥6.92 Billion CN¥5.96 Billion CN¥4.65 Billion
Total Current Assets CN¥6.81 Billion CN¥6.37 Billion CN¥4.93 Billion CN¥3.98 Billion CN¥2.91 Billion
Cash & Equivalents — — — — —
Short-term Investments CN¥8.13 Million CN¥1.19 Billion CN¥17.58 Million CN¥563.97K —
Net Receivables CN¥467.93 Million CN¥624.46 Million CN¥388.96 Million CN¥411.40 Million CN¥416.55 Million
Inventory CN¥3.86 Billion CN¥3.20 Billion CN¥2.03 Billion CN¥2.23 Billion CN¥1.79 Billion
Property, Plant & Equipment — — CN¥1.54 Billion CN¥1.48 Billion CN¥1.24 Billion
Goodwill CN¥593.86K CN¥593.86K CN¥593.86K CN¥593.86K CN¥593.86K
Total Liabilities CN¥5.87 Billion CN¥5.01 Billion CN¥3.71 Billion CN¥3.17 Billion CN¥2.59 Billion
Total Current Liabilities CN¥4.60 Billion CN¥3.95 Billion CN¥2.76 Billion CN¥2.68 Billion CN¥1.43 Billion
Long-term Debt CN¥1.07 Billion CN¥865.00 Million CN¥770.00 Million CN¥303.10 Million CN¥1.03 Billion
Net Debt CN¥1.57 Billion CN¥2.05 Billion CN¥1.69 Billion CN¥1.71 Billion CN¥1.77 Billion
Total Stockholder Equity CN¥3.11 Billion CN¥3.47 Billion CN¥3.16 Billion CN¥2.79 Billion CN¥2.06 Billion
Retained Earnings CN¥1.89 Billion CN¥1.89 Billion CN¥1.52 Billion CN¥1.18 Billion CN¥905.13 Million

Chenguang Biotech Group Cash Flow Statement — Operating, Investing & Financing Activities

This cash flow statement breaks down how Chenguang Biotech Group generates and spends cash across operating, investing, and financing activities each fiscal year, including free cash flow and capital expenditures.

Fiscal Year 20242023202220212020
Operating Cash Flow CN¥-222.81 Million CN¥-510.91 Million CN¥734.81 Million CN¥63.90 Million CN¥529.41 Million
Capital Expenditures CN¥149.54 Million CN¥189.20 Million CN¥176.03 Million CN¥280.82 Million CN¥436.88 Million
Free Cash Flow CN¥-372.35 Million CN¥-700.11 Million CN¥558.78 Million CN¥-216.92 Million CN¥92.54 Million
Investing Cash Flow CN¥-440.95 Million CN¥-525.83 Million CN¥-696.40 Million CN¥-264.76 Million CN¥-442.14 Million
Financing Cash Flow CN¥103.80 Million CN¥1.30 Billion CN¥39.05 Million CN¥540.96 Million CN¥242.66 Million
Dividends Paid CN¥174.05 Million CN¥157.61 Million CN¥69.26 Million CN¥53.28 Million CN¥24.08 Million
Stock-Based Compensation — — — — —
Depreciation CN¥166.95 Million CN¥152.83 Million CN¥145.32 Million CN¥130.74 Million CN¥112.29 Million
Change in Cash CN¥-570.46 Million CN¥254.03 Million CN¥72.51 Million CN¥335.75 Million CN¥326.02 Million

Chenguang Biotech Group Earnings History — EPS Actual vs. Analyst Estimates

Track Chenguang Biotech Group's quarterly earnings per share (EPS) against Wall Street estimates, along with the earnings surprise percentage for each reporting period.

Report Date EPS Actual EPS Estimate Surprise
Oct 25, 2025 0.19 0.19 +1.93%
Aug 25, 2025 0.21 0.24 -12.50%
Apr 07, 2025 0.06 -0.12 +150.00%
Dec 31, 2024 0.06 -0.12 +149.18%
Oct 25, 2024 -0.07 0.11 -163.64%
Aug 27, 2024 0.12 — —
Apr 17, 2024 0.15 0.19 -21.05%
Feb 01, 2024 0.16 0.19 -15.79%